ストックスクリーナーアプリを入手
2.44
6.87%
-0.18
プレマーケット:
2.50
0.06
+2.46%
Nautilus Biotechnology Inc (NAUT) 最新ニュース
Sujal Patel Buys 25,000 Shares of Nautilus Biotechnology (NASDAQ:NAUT) Stock - MarketBeat
Executive Parag Mallick receives 280,000 stock options at Nautilus (NAUT) - Stock Titan
Nautilus (NAUT) General Counsel receives 160,000-share stock option grant - Stock Titan
What’s the MACD signal for Nautilus Biotechnology Inc.2025 Winners & Losers & Safe Entry Point Identification - mfd.ru
Nautilus Biotechnology names Amber Faust as Vice President of Sales to drive proteomics expansion - Traders Union
NAUT: New proteomics platform promises comprehensive, reproducible protein analysis with broad applications - TradingView
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales - BioSpace
Nautilus Biotechnology appoints Amber Faust as VP of sales By Investing.com - Investing.com India
Nautilus Biotechnology appoints proteomics commercial leader Amber Faust as vice president of sales - marketscreener.com
Nautilus Biotechnology appoints Amber Faust as VP of sales - Investing.com
Sales veteran joins Nautilus to push single-molecule proteomics into labs - Stock Titan
Guggenheim Forecasts Strong Price Appreciation for Nautilus Biotechnology (NASDAQ:NAUT) Stock - Defense World
Aug Big Picture: What are PROFs growth levers2025 EndofYear Setup & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
NAUT Should I Buy - Intellectia AI
Nautilus Biotechnology (NAUT) Target Price Raised by Guggenheim - GuruFocus
Nautilus debuts Voyager platform in push toward next-gen proteomics - Longevity.Technology
Nautilus Biotechnology (NASDAQ:NAUT) Price Target Raised to $4.00 at Guggenheim - MarketBeat
Nautilus Biotechnology (NAUT) Target Price Raised by Guggenheim | NAUT Stock News - GuruFocus
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2025 Earnings Call Transcript - Insider Monkey
Nautilus Biotechnology stock price target raised to $4 by Guggenheim - Investing.com Canada
Nautilus (NAUT) Q4 2025 Earnings Call Transcript - The Globe and Mail
Nautilus Biotechnology, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Nautilus Biotechnology Q4 Earnings Call Highlights - MarketBeat
Nautilus projects 15%-20% expense growth in 2026 as early access program ramps up - MSN
Nautilus Biotechnology (NASDAQ:NAUT) Announces Earnings Results - MarketBeat
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2025 Financial Results - Investing News Network
Earnings call transcript: Nautilus Biotechnology Q4 2025 shows cost cuts By Investing.com - Investing.com Australia
Earnings call transcript: Nautilus Biotechnology Q4 2025 shows cost cuts - Investing.com Nigeria
BRIEF-Nautilus Biotechnology Q4 EPS USD -0.11 - TradingView
Nautilus Biotechnology Inc. recently stated that the company does not expect to generate substantial revenue from early access program collaborations before 2026. - Bitget
Nautilus Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025 - marketscreener.com
Nautilus Biotechnology Q4 2025 Earnings Call Transcript - MarketBeat
Market Fear: Whats the RSI of Nautilus Biotechnology Inc stockMarket Risk Report & Capital Protection Trade Alerts - baoquankhu1.vn
Nautilus Biotechnology (NAUT) trims 2025 loss, sees cash runway through 2027 - Stock Titan
Nautilus Biotechnology Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, at US HUPO 2026 - BioSpace
Nautilus Biotechnology IncCommercial launch of Voyager platform expected in late 2026 - marketscreener.com
Nautilus Biotechnology, Inc. Unveils Voyager Platform, Enabling Single-Molecule Iterative Mapping, At US HUPO 2026 - marketscreener.com
Nautilus machine maps 10 billion proteins to study Alzheimer’s - Stock Titan
Ideas Watch: Does Nautilus Biotechnology Inc have a competitive edge2025 Geopolitical Influence & AI Driven Price Forecasts - baoquankhu1.vn
Nautilus Biotechnology (NAUT) to Release Earnings on Thursday - Defense World
Is Nautilus Biotechnology Inc. stock a smart retirement pickMarket Performance Recap & Technical Pattern Alert System - mfd.ru
Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference - Bluefield Daily Telegraph
Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Decreases By 16.6% - MarketBeat
Will Nautilus Biotechnology Inc. stock hit new highs in YEARWeekly Trend Recap & Proven Capital Preservation Tips - mfd.ru
Pullback Watch: Should I hold or sell Nautilus Biotechnology Inc nowTrade Signal Summary & Real-Time Market Sentiment Reports - baoquankhu1.vn
How Nautilus Biotechnology Inc. stock reacts to job market data2025 Risk Factors & Daily Volume Surge Signals - mfd.ru
3 Penny Stocks With Market Caps Over $50M To Watch - simplywall.st
Earnings Miss: Does Nautilus Biotechnology Inc have strong fundamentalsStop Loss & Real-Time Buy Signal Notifications - baoquankhu1.vn
Nautilus Biotechnology explores multiomics to mitigate space travel effects - Traders Union
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 - The Manila Times
Risk Hedge: Is GP Act III Acquisition Corp Equity Warrant stock suitable for long term investing - baoquankhu1.vn
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Update - MarketBeat
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with the Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson's Disease - marketscreener.com
Nautilus Biotechnology announces research collab with WCM-Q, MJFF - TipRanks
Parkinson’s project backed by $1.6M grant maps a key brain protein - Stock Titan
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease - GlobeNewswire
Nautilus Biotechnology Insider Confidence Rewarded, Stock Hits US$275m Market Cap - 富途牛牛
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):